Microglial inhibitory mechanism of Coenzyme Q10 against Aβ (1-42) induced cognitive dysfunctions: possible behavioral, biochemical, cellular and histopathological alterations
Rationale: Alzheimer’s disease (AD) is a debilitating disease with complex pathophysiology. Amyloid beta (Aβ) (1-42) is a reliable model of AD that recapitulates many aspects of human AD. Objective: The present study has been designed to investigate the neuroprotective potential of Coenzyme Q10 (CoQ...
Main Authors: | Arti eSingh, Anil eKumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00268/full |
Similar Items
-
A review on mitochondrial restorative mechanism of antioxidants in Alzheimer’s disease and other neurological conditions
by: Anil eKumar, et al.
Published: (2015-09-01) -
Photobiomodulation and Coenzyme Q10 Treatments Attenuate Cognitive Impairment Associated With Model of Transient Global Brain Ischemia in Artificially Aged Mice
by: Farzad Salehpour, et al.
Published: (2019-03-01) -
Coenzyme Q10 and Neurological Diseases
by: Gabriele Siciliano, et al.
Published: (2009-12-01) -
The Value of Coenzyme Q10 Determination in Mitochondrial Patients
by: Delia Yubero, et al.
Published: (2017-03-01) -
The Relationship between Mitochondrial Reactive Oxygen Species Production and Mitochondrial Energetics in Rat Tissues with Different Contents of Reduced Coenzyme Q
by: Karolina Dominiak, et al.
Published: (2021-03-01)